Tangka Parranthi “Sparking Hope” – Another successful ANZCHOG Annual Scientific Meeting
More than 350 delegates came together recently to attend the ANZCHOG 2024 Annual Scientific Meeting (ASM) in Adelaide (Tarntanya).
Shining the spotlight on nutrition and dietetics in paediatric oncology
During Childhood Cancer Awareness Month, we’re sharing the A to Z of ANZCHOG on our LinkedIn and Twitter. The A to Z highlights a comprehensive look at some of the work we do both in clinical trials and as the peak body for paediatric haematology and oncology in Australia and New Zealand.
Game-changing funding announcement for children’s cancer research in Western Australia
We are thrilled for ANZCHOG’s very own Chair, Nick Gottardo, and the amazing teams at Perth Children’s Hospital and Telethon Kids Institute for securing game-changing funding for children’s cancer research and treatments in Western Australia.
ANZCHOG welcomes four new Life Members
At this year’s Annual Scientific Meeting Gala Dinner, four pioneers of childhood cancer treatments received ANZCHOG Life Membership.
A promising advancement for New Zealand children and adolescents with cancer
In positive news for New Zealand children and adolescents with cancer, the ZERO2 study has opened at Starship Children’s Hospital, Auckland.
Perth Children’s Hospital Opens New Clinical Trial for Children and Adolescents with Ewing Sarcoma
On the eve of Sarcoma and Bone Cancer Awareness Month, Perth Children’s Hospital has become the first international site outside of the United Kingdom to open an innovative clinical trial for children and adolescents with newly diagnosed Ewing Sarcoma.
Management of children with DIPG: ANZCHOG Position Statement
The ANZCHOG Central Nervous System (CNS) Tumour Group has recently published a position statement for the management of children with Diffuse Intrinsic Pontine Glioma (DIPG) in Australia and New Zealand.
Interfant-21 Opens at First Australian Site
Earlier this week, Perth Children’s Hospital became the first Australian site to open Interfant-21, an international phase 3 clinical trial.